|
![]() |
Fibroblast growth factor-This page contains recent news articles, when available, and an overview of Fibroblast growth factor- but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....treated with fibroblast growth factor-2 (FGF-2), a naturally occurring protein that has been studied extensively for its neuroprotective properties. Newswise (press release) Aethlon Medical Announces Cancer Treatment License - May 21, 2008 ...factors involves the immobilization of drug agents able to selectively bind vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), Business Wire (press release), Gene Therapy: Medicine of the 21st Century - May 13, 2008 These include the endothelial growth factors, Vascular Endothelial Growth Factor (VEGF), Hepatocyte Growth Factor (HGF) and Fibroblast Growth factor (FGF). Express Pharma, Targeting N-Cadherin Boosts Melanoma Response to Chemotherapy - May 27, 2008 ...decreases in the expression of the fibroblast growth factor receptor type 1, increased apoptosis, and changes in intracellular signaling associated with Cancerpage.com, Vical Reports First Quarter 2008 Financial Results and Updates Key ... - May 8, 2008 ...of its fibroblast growth factor 1 (FGF-1) angiogenesis product candidate in key global markets and anticipates filing for marketing approvals in 2010. Earthtimes (press release), Scientists Uncover How Specific SNPs Elevate Breast Cancer Risk - May 6, 2008 Researchers discovered that SNPs in fibroblast growth factor receptor 2 (FGFR2) associated with increased risk of breast cancer alter the way regulatory Genetic Engineering News (press release), Basal Expression of Bone Morphogenetic Protein Receptor Is Reduced ... - May 16, 2008 Mesenchyme-derived fibroblast growth factor-10 can induce this expression of BMP-4 (6). BMP-4 directly increases the number of alpha-smooth muscle actin RedOrbit, Changes in specific gene boosts breast cancer risk - May 5, 2008 ...has discovered how specific changes in a gene called fibroblast growth factor receptor 2 (FGFR2) increase the risk of developing breast cancer. DailyIndia.com, Hyperactivity Is Associated With Decreased Numbers Of Interneurons - May 15, 2008 Müller Smith and colleagues demonstrate that mice lacking the fibroblast growth factor receptor 1 (FGFR1) display profound, non-habituating hyperactivity Medical News Today (press release), Multiplicity of cerebrospinal fluid functions: new challenges in ... - May 14, 2008 ...and neuroendocrine factors (ie, coordinated regulation by atrial natriuretic peptide, arginine vasopressin and basic fibroblast growth factor). 7thSpace Interactive (press release), Specific Gene Increases Susceptibility To Breast Cancer - May 5, 2008 Previous work showed that variants in the gene called fibroblast growth factor receptor 2 (FGFR2) were associated with increased risk of the disease, Science Daily (press release) Hyperactivity is associated with decreased numbers of interneurons - May 13, 2008 Müller Smith and colleagues demonstrate that mice lacking the fibroblast growth factor receptor 1 (FGFR1) display profound, non-habituating hyperactivity EurekAlert (press release), Hyperactivity is associated with decreased numbers of interneurones - May 13, 2008 Mueller Smith and colleagues demonstrate that mice lacking the fibroblast growth factor receptor 1 (FGFR1) display profound, non-habituating hyperactivity Science Centric, New Therapies Could Change Cancer Treatment Strategies - 23 Apr 2008 By analyzing blood samples from patients, the researchers found that the biomarkers FGF (fibroblast growth factor) and Tie-2 were associated with tumor eMaxHealth.com, Response Genetics, Inc. Announced Results of Pre-Clinical Studies ... - Apr 17, 2008 ...basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGFA) gene expressions. FOXBusiness Low-Molecular-Weight Heparins Inhibit Tumor Growth, Study Shows - Apr 14, 2008 This study tested the hypothesis that sequestering blood vessel growth factors, such as fibroblast growth factor (FGF), would interfere with angiogenesis Science Daily (press release) Treatment Target For Liver Cancer Recurrence And Survival Identified - Apr 10, 2008 The investigators found that SULF2 did the opposite -- it increased binding of a specific growth factor, fibroblast growth factor 2 (FGF2), to tumor cells, Science Daily (press release) Human vascular system in mice - Apr 14, 2008 The three-dimensional analysis of blood vessels formed shows that growth factors such as fibroblast growth factor-2 effectively promote the coating of the EurekAlert (press release), TransMolecular Unveils First Data on TM601 Anti-Angiogenic ... - Apr 14, 2008 ...which was stimulated by vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), or lipopolysaccharide (LPS). Business Wire (press release), Annual Report to shareholders - Mar 27, 2008 In addition, therapeutic potential of the MorphoSys The fibroblast growth factor (FGF) osteoblasts are a critical component fully human antibodies. Sydney Morning Herald, Method To Deliver Molecules Within Embryonic Stem Cells Improves ... - Apr 9, 2008 The results revealed enhanced expression of fibroblast growth factor 5 (FGF-5) -- a marker for primitive ectoderm -- in the embryoid bodies mixed with Science Daily (press release) Compensatory role for Pyk2 during angiogenesis in adult mice ... - Apr 7, 2008 Abbreviations used in this paper: BAEC, bovine aortic endothelial cell; bFGF, basic fibroblast growth factor; EC, endothelial cell; HUVEC, human umbilical Journal of Cell Biology (subscription) 'Mutant' Proteins Could Lead To New Treatment For Heart Disease - Mar 24, 2008 A new approach to the problem called therapeutic coronary angiogenesis is creating hope through the injection of human fibroblast growth factor protein into Science Daily (press release) Heading for the BIG Time - Apr 7, 2008 Ponder described how variation in a gene called fibroblast growth factor receptor 2 (FGFR2) is associated with breast cancer. Judah Folkman, a legend among Scientist, Girl undergoes surgery to gain height - Apr 5, 2008 After her doctors in Chennai confirmed that the FHFR - fibroblast growth factor receptor - gene was mutated in Naba, a team led by orthopedic surgeon S Times of India, NCI Awards Strategic Diagnostics First Round of Funding to Develop ... - Apr 10, 2008 The antigens for which antibodies are being produced in this round include cystatin B, fibroblast growth factor 1, interleukin 1 alpha, and squamous cell Proteo Monitor, CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II ... - Apr 1, 2008 These two devices will be used in CVBT's Phase II heart trial, in which the potent angiogenic protein human Fibroblast Growth Factor -1 (FGF-1) will be CNNMoney.com (press release) ‘Mutant’ proteins could pave way for new heart disease treatment - Mar 24, 2008 The new approach to the problem is called therapeutic coronary angiogenesis, which is creating hope through the injection of human fibroblast growth factor Thaindian.com, Drugs in the pipeline: new therapies that could change treatment ... - Apr 15, 2008 By analyzing blood samples from patients, the researchers found that the biomarkers FGF (fibroblast growth factor) and Tie-2 were associated with tumor Genetic Engineering News (press release), Epithelial Fibroblast Growth Factor Receptor 1 Regulates Enamel ... - Feb 22, 2008 During tooth development, fibroblast growth factor (FGF) signaling is critical for regulating reciprocal epithelial and mesenchymal interactions. Journal of Dental Research (subscription), Vical Reports 2007 Financial Results and Progress in Product ... - Feb 21, 2008 Update by the company's licensee, sanofi aventis Group, on an ongoing Phase 3 trial for the DNA-based delivery of Fibroblast Growth Factor 1 (FGF-1), PR Newswire (press release), Drug Combo May Fight Prostate Cancer - Feb 18, 2008 This one's called fibroblast growth factor. "We reasoned that combining two different anti-angiogenesis drugs that work by two different pathways to get to WebMD Neurobiological Technologies, Inc. and Buck Institute Partner to ... - Mar 3, 2008 ...involving fibroblast growth factor-2 (FGF-2), a naturally occurring protein that has been studied extensively for its neuroprotective properties. Earthtimes, Genetic Region Linked to Breast Cancer Risk - Mar 3, 2008 They found a 26% increase in risk associated with the region on chromosome 10 that includes the gene for fibroblast growth factor receptor 2, MedPage Today, Postlaminectomy Kyphosis in an Achondroplastic Adolescent Treated ... - Feb 15, 2008 1 It is an autosomal-dominant condition caused by mutation in the gene encoding fibroblast growth factor receptor 3. 2 Spinal stenosis is a common problem Ortho SuperSite, CVBT’s Pharmacoeconomics Strategy Recognized in Nature ... - Feb 14, 2008 ...treats severe coronary heart disease (CHD) and contains the active pharmaceutical ingredient (API) human fibroblast growth factor-1 (FGF-1). Business Wire (press release), Neuroplasticity in Schizophrenia and Atypical Antipsychotics - Feb 5, 2008 ...[62] and produce marked elevation of BDNF and fibroblast growth factor 2 (FGF-2) mRNA in rat hippocampus when the NMDA receptor antagonist MK-801 is Medscape (subscription) Stockwire.com: Speak with other shareholders about: (Nasdaq:FSTR ... - Feb 4, 2008 The company uses an active pharmaceutical ingredient, the 141 amino acid form of fibroblast growth factor-1, in its drug candidates, which facilitates the Trading Markets (press release), Atorvastatin impairs the myocardial angiogenic response to chronic ... - Jan 17, 2008 Expression of vascular endothelial growth factor, Tie-2, fibroblast growth factor receptor-1, and endothelial nitric oxide synthase was similar in both The Journal of Thoracic and Cardiovascular Surgery eBriefing - Jan 15, 2008 Then in 2004, the US Food and Drug Administration approved Avastin (bevacizumab), Tarceva (erlotinib, which blocks VEGF, FGF [fibroblast growth factor], The New York Academy of Sciences, Hyperoxia and EGFL7: saving cells from too much of a good thing - Jan 15, 2008 ...[ISI][Medline] Bikfalvi A, Savona C, Perollet C, Javerzat S. New insights in the biology of fibroblast growth factor-2. Angiogenesis 1: 155–173, 1998. AJP-Lung Physiology (subscription) Reader's Digest Article Calls CVBT's Protein Treatment a 'Gleam of ... - Jan 9, 2008 She learned of CVBT's new procedure in which its drug, containing the active protein fibroblast growth factor-1 (FGF-1), was injected into the heart thereby FOXNews CVBT: Shares Open Higher on Positive Article in February "Reader's ... - Jan 9, 2008 The active pharmaceutical ingredient in the Company's drug candidates is Fibroblast Growth Factor 1 (FGF-1), which has multiple applications for the Trading Markets (press release), Early growth response factor-1 in acute lung injury - Nov 12, 2007 ...fibroblast growth factor 2 (fibrosis) (13), VEGF (vascular permeability), CD44 (extracellular matrix turnover and resolution of inflammation), AJP-Lung Physiology (subscription) Pourquie Lab demonstrates role of growth factor in vertebrae formation - Oct 30, 2007 The Stowers Institute’s Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, EurekAlert (press release), Full Text - Nov 1, 2007 Fibroblast growth factor-2 (Fgf-2) (3), glial growth factor-2 (4), the neurotransmitter substance P (5), and the iron transport protein transferrin (6) Science Magazine (subscription) Healthy earnings and revenue growth at Germany's morphosys - Oct 25, 2007 ...abd Serotec against the human fibroblast growth factor receptor FGFR5 for target validation and pre-clinical studies as part of its Zyrogen programme, Pharma Times (subscription), Plant Used by cardiovascular biotherapeutics’ California State License - Nov 1, 2007 Phage produces all the human fibroblast growth factor-1 (FGF-1) that CVBT utilizes in its prelinical and clinical development programs. Genetic Engineering News (press release), CVBT: New Manufacturing Facility in San Diego Receives California ... - Nov 1, 2007 ...human fibroblast growth factor-1 (FGF-1), is manufactured has received a California Food and Drug Board license to manufacture pharmaceuticals for Trading Markets (press release), Positive Results from CVBT’s Phase I No-Option Heart Disease ... - Nov 5, 2007 Results from the Phase I trial using CVBT’s human fibroblast growth factor 1 (FGF-1) indicated that the drug candidate was a safe and biologically-active Business Wire (press release), New Medical Treatment for Women’s Heart Disease Discussed in Dr ... - Oct 23, 2007 CVBT is focused on further developing formulations of the protein drug candidate, human fibroblast growth factor 1 (FGF-1) that Dr. Stegmann discovered for Business Wire (press release), How Phosphorus Affects CKD Patients - Oct 22, 2007 ...level and various hormones with phosphaturic properties, the main ones being parathyroid hormone (PTH) 2 and fibroblast growth factor 23 (FGF-23). Renal and Urology News, Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce ... - Sep 20, 2007 The plasmid DNA (pDNA) therapy encodes Fibroblast Growth Factor 1 (FGF-1), a growth factor that stimulates the growth of blood vessels, and is intended to CNNMoney.com MorphoSys expands R&D agreement with Genesis Research of New Zealand - Oct 8, 2007 Genesis will seek to identify within MorphoSys's collection of antibodies those that connect to so-called fibroblast growth factor receptors, Forbes, Studies Supported by NIH to Confirm Potential of Corgentin to ... - Oct 4, 2007 The study will also evaluate the comparative ability of fibroblast growth factor-2 (FGF-2) to protect heart tissue. The objective of this treatment approach Genetic Engineering News (press release), New Insights into the Control of Stem Cells: Keeping the Right Balance - Sep 15, 2007 They include factors such as FGF (fibroblast growth factor) and EGF (epidermal growth factor). They regulate a different pathway, which involves tyrosine Science Daily (press release) A promising R&D portfolio, well positioned to deliver future growth - Sep 17, 2007 NV1FGF (fibroblast growth factor): Phase III in progress. The first gene therapy aimed at reducing amputations in patients suffering from critical limb Newsdesk, CardioVascular BioTherapeutics: The Wall Street Analyst Forum ... - Sep 20, 2007 CardioVascular BioTherapeutics is a biopharmaceutical company developing formulations of Fibroblast Growth Factor-1, FGF-1 to treat a number of diseases Seeking Alpha, MorphoSys Enters Therapeutic Research - Oct 7, 2007 ...against thehuman fibroblast growth factor receptor FGFR5 for TARGET validationand pre-clinical studies as part of its proprietary Zyrogen program. Ad-Hoc-News (Pressemitteilung), CardioVascular BioTherapeutics Completes Phase I Wound Healing Trial - Oct 3, 2007 ...candidate (CVBT-141B), formulated with human fibroblast growth factor -1 (FGF-1), in patients suffering from either diabetic or venous stasis ulcers. NDTV.com, In Dogs, A Shortcut To Mapping Disease Genes - Oct 2, 2007 The region includes three fibroblast growth factor (FGF) genes that play crucial roles in development. Further analysis revealed the precise genetic cause Science Daily (press release) Sanofi-Aventis Starts Phase 3 Clinical Trial Of NV1FGF ... - Sep 20, 2007 The plasmid DNA or pDNA therapy encodes Fibroblast Growth Factor 1 (FGF-1 | charts | news | PowerRating), a growth factor that stimulates the growth of Trading Markets, Genesis Research collaborates with MorphoSys - Oct 7, 2007 ...against the human fibroblast growth factor receptor FGFR5 for target validation and pre-clinical studies as part of its proprietary Zyrogen program. Trading Markets (press release), Scientific advances bring hope for families - Oct 1, 2007 During their research, the gene known as fibroblast growth factor receptor 3, or FGFR3, was considered a possible candidate. The News Journal, What's New in Orthopaedic Rehabilitation - Oct 1, 2007 ...insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), and basic fibroblast growth factor (bFGF). Journal of Bone and Joint Surgery (subscription) Scientists delve into dog genome to find disease genes - Oct 4, 2007 They found that the ridgeback trait is caused when the dogs have multiple copies of a region of the genome containing genes for the fibroblast growth factor NEWSFOOD.com Primo piano, Sanofi-Aventis Initiates Phase III TAMARIS Trial - Sep 21, 2007 According to sanofi-aventis and Vical, the plasmid DNA therapy encodes fibroblast growth factor 1, which stimulates the growth of blood vessels and reduces FDA news (subscription), Sinobiomed Updates on Company Progress - Sep 20, 2007 Chinese government approval to begin marketing its newest patented product, aFGF (acidic Fibroblast Growth Factor) a drug for ulceration, severe burns Web Services Journal, DRUGS IN DEVELOPMENT - Sep 18, 2007 ...an FGFR3 (fibroblast growth factor receptor 3) inhibitor, in collaboration with Novartis Oncology; a Phase I study of perifosine, Revlimid(r), PharmaLive.com (press release), LIPODISTROPHIA PATHOLOGY - MULTI RAYS PULSE THERAPY BY MEDIXSYSTEME - Sep 17, 2007 It need to be recall that therapeutic ultrasounds induce vasodilation at skin surface level and stimulation of the fibroblast growth factor. openPR (press release), : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |